Rutgers: Common Metabolic Enzyme Could Predict Cancer Immunotherapy Benefits - and Help More Patients Respond
April 02, 2026
April 02, 2026
NEW BRUNSWICK, New Jersey, April 2 (TNSjou) -- Rutgers University issued the following news:
* * *
Common Metabolic Enzyme Could Predict Cancer Immunotherapy Benefits -- and Help More Patients Respond
By Andrew Smith
In a Rutgers study, mice given a two-drug combination survived at far higher rates, suggesting a strategy that could improve the effectiveness of some cancer immunotherapies.
Immunotherapies have transformed cancer tre . . .
* * *
Common Metabolic Enzyme Could Predict Cancer Immunotherapy Benefits -- and Help More Patients Respond
By Andrew Smith
In a Rutgers study, mice given a two-drug combination survived at far higher rates, suggesting a strategy that could improve the effectiveness of some cancer immunotherapies.
Immunotherapies have transformed cancer tre . . .